30516108|t|Effect of S-equol and Soy Isoflavones on Heart and Brain.
30516108|a|BACKGROUND: Observational studies in Asia show that dietary intake of soy isoflavones had a significant inverse association with coronary heart disease (CHD). A recent randomized controlled trial (RCT) of soy isoflavones on atherosclerosis in the US, however, failed to show their benefit. The discrepancy may be due to the much lower prevalence of S-equol producers in Westerners: Only 20-30% of Westerners produce S-equol in contrast to 50-70% in Asians. S-equol is a metabolite of dietary soy isoflavone daidzein by gut microbiome and possesses the most antiatherogenic properties among all isoflavones. Several short-duration RCTs documented that soy isoflavones improves arterial stiffness. Accumulating evidence shows that both atherosclerosis and arterial stiffness are positively associated with cognitive decline/dementia. Therefore, potentially, soy isoflavones, especially S-equol, are protective against cognitive decline/dementia. METHODS/RESULTS: This narrative review of clinical and epidemiological studies provides an overview of the health benefits of soy isoflavones and introduces S-equol. Second, we review recent evidence on the association of soy isoflavones and S-equol with CHD, atherosclerosis, and arterial stiffness as well as the association of atherosclerosis and arterial stiffness with cognitive decline/ dementia. Third, we highlight recent studies that report the association of soy isoflavones and S-equol with cognitive decline/dementia. Lastly, we discuss the future directions of clinical and epidemiological research on the relationship of S-equol and CHD and dementia. CONCLUSIONS: Evidence from observational studies and short-term RCTs suggests that S-equol is anti-atherogenic and improves arterial stiffness and may prevent CHD and cognitive impairment/ dementia. Well-designed long-term (>= 2years) RCTs should be pursued.
30516108	10	17	S-equol	Chemical	MESH:D060754
30516108	22	37	Soy Isoflavones	Chemical	MESH:D007529
30516108	128	143	soy isoflavones	Chemical	MESH:D007529
30516108	187	209	coronary heart disease	Disease	MESH:D003327
30516108	211	214	CHD	Disease	MESH:D003327
30516108	263	278	soy isoflavones	Chemical	MESH:D007529
30516108	282	297	atherosclerosis	Disease	MESH:D050197
30516108	407	414	S-equol	Chemical	MESH:D060754
30516108	474	481	S-equol	Chemical	MESH:D060754
30516108	515	522	S-equol	Chemical	MESH:D060754
30516108	554	564	isoflavone	Chemical	MESH:D007529
30516108	565	573	daidzein	Chemical	MESH:C004742
30516108	652	663	isoflavones	Chemical	MESH:D007529
30516108	709	724	soy isoflavones	Chemical	MESH:D007529
30516108	734	752	arterial stiffness	Disease	MESH:C566112
30516108	792	807	atherosclerosis	Disease	MESH:D050197
30516108	812	830	arterial stiffness	Disease	MESH:C566112
30516108	862	879	cognitive decline	Disease	MESH:D003072
30516108	880	888	dementia	Disease	MESH:D003704
30516108	914	929	soy isoflavones	Chemical	MESH:D007529
30516108	942	949	S-equol	Chemical	MESH:D060754
30516108	974	991	cognitive decline	Disease	MESH:D003072
30516108	992	1000	dementia	Disease	MESH:D003704
30516108	1128	1143	soy isoflavones	Chemical	MESH:D007529
30516108	1159	1166	S-equol	Chemical	MESH:D060754
30516108	1224	1239	soy isoflavones	Chemical	MESH:D007529
30516108	1244	1251	S-equol	Chemical	MESH:D060754
30516108	1257	1260	CHD	Disease	MESH:D003327
30516108	1262	1277	atherosclerosis	Disease	MESH:D050197
30516108	1283	1301	arterial stiffness	Disease	MESH:C566112
30516108	1332	1347	atherosclerosis	Disease	MESH:D050197
30516108	1352	1370	arterial stiffness	Disease	MESH:C566112
30516108	1376	1393	cognitive decline	Disease	MESH:D003072
30516108	1395	1403	dementia	Disease	MESH:D003704
30516108	1471	1486	soy isoflavones	Chemical	MESH:D007529
30516108	1491	1498	S-equol	Chemical	MESH:D060754
30516108	1504	1521	cognitive decline	Disease	MESH:D003072
30516108	1522	1530	dementia	Disease	MESH:D003704
30516108	1637	1644	S-equol	Chemical	MESH:D060754
30516108	1649	1652	CHD	Disease	MESH:D003327
30516108	1657	1665	dementia	Disease	MESH:D003704
30516108	1750	1757	S-equol	Chemical	MESH:D060754
30516108	1766	1777	atherogenic	Disease	MESH:D050197
30516108	1791	1809	arterial stiffness	Disease	MESH:C566112
30516108	1826	1829	CHD	Disease	MESH:D003327
30516108	1834	1854	cognitive impairment	Disease	MESH:D003072
30516108	1856	1864	dementia	Disease	MESH:D003704
30516108	Negative_Correlation	MESH:D060754	MESH:D050197
30516108	Negative_Correlation	MESH:D060754	MESH:D003704
30516108	Negative_Correlation	MESH:D060754	MESH:D003072
30516108	Negative_Correlation	MESH:D007529	MESH:D003072
30516108	Negative_Correlation	MESH:D007529	MESH:D003704
30516108	Positive_Correlation	MESH:D007529	MESH:C566112
30516108	Negative_Correlation	MESH:D007529	MESH:D003327
30516108	Positive_Correlation	MESH:D060754	MESH:C566112
30516108	Negative_Correlation	MESH:D060754	MESH:D003327

